🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very interesting session on the role of the multidisciplinary team in lung oncology. Among the actors of the decision the patient first of all with the great testimony of TerriConneran , KRas patient alive after 7 years from the diagnosis #WCLC24

Wow. PFS HR 0.54 vs the current standard. This exceeded my expectation by FAR. The mPFS of pembro was 5.8m is basically the same as what we saw in KEYNOTE 042. Ivonescimab gives a PFS of 11.1m with early and consistent separation of the curves. #WCLC24

John Heymach’s conclusions on discussing HARMONi-2. V nice overview and balanced discussion #WCLC24 IASLC

Absolute agreement

Maybe yes

BARI, 8va CONFERENZA DI ONCOLOGIA POLMONARE DALLA PREVENZIONE ALLA TERAPIA DELLA MALATTIA AVANZATA | Ilikepuglia.it - Magazine di informazione regionale della Puglia ilikepuglia.it/06/11/2024/bar…

Thanks to Dr. Domenico Galetta for the invitation to the VIII Conferenza Oncologia Polmonare in Bari. Comprehensive program endorsed by IASLC from prevention and screening to locally advanced and metastatic. Looking forward to some great talks!

The right side of the moon

Dr. Solange Peters with a grand overview of unresectable stage III NSCLC at VIII Conferenza Oncologia Polmonare. PACIFIC is our standard. Hard lessons with concurrent chemoradiation and immunotherapy with negative results from PACIFIC2 and CheckMate 73L (per press release).

Excellent presentation on the most complex lung pathology:SCLC Stephen V Liu, MD

a great debate sparked by Federico Cappuzzo speech in VIII Lung cancer conference in Bari

A new start! Biomarkers Atlas is for an Italian project that addresses the community of oncologists but looks to patients with lung cancer to create a "concrete" photograph of a dynamic disease but known in more and more detail. Thanks to the friends Silvia Novello and

Congratulations Umberto! It is likely that this will be increasingly advantageous as the years go by (the work refers to 2021). Do you think that we can also transfer the data to early-stage disease?

🧬Synergy between research and clinical practice🔬 The ATLAS Foundation is also mentioned on Repubblica📝 Click on the following link to access the full article🔗 repubblica.it/salute/dossier… #WeAreAtlas Domenico Galetta | Umberto Malapelle

Thanks Drs Stephen V Liu, MD and Tina Cascone for the excellent #TexasLung25! Amazing meeting, discussions and great atmosphere! I enjoyed our session on biomarkers testing and MRD with good friends David Gandara Christine Lovly, MD, PhD, FASCO Sandip Patel MD FASCO IDEOlogy Health

Eve of #RomeLung25 - catching up with friends from all over, ready to discuss, debate, learn from each other and work out new strategies for lung cancer! Marina Garassino Cecilia Pompili MD PhD FACS Domenico Galetta Hossein Borghaei, DO Alfredo Addeo MD fabiana cecere DOLORES ISLA

Very interesting and intense discussion on the role of neoadjuvant vs perioperative chemo-immunotherapy. There is still no definitive consensus, many questions remain open, but a new path is now fully achievable #RomeLung25

Dr Silvia Novello presenting the ATLAS an important Italian project on testing Cancer Registry. Congratulations to founders and collaborators of this platform at #RomeLung25 Biomarkers Atlas Umberto Malapelle [email protected] Sara Domenico Galetta Giulia pasello